Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Comparison of outcomes on hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs) in anaemia associated with chronic kidney disease: network meta-analyses in dialysis and non-dialysis dependent populations.
Clin Kidney J. 2023 Dec 7;17(1):sfad298. doi: 10.1093/ckj/sfad298. eCollection 2024 Jan.
Clin Kidney J. 2023.
PMID: 38250252
Free PMC article.
The ASCEND-NHQ randomized trial found positive effects of daprodustat on hemoglobin and quality of life in patients with non-dialysis chronic kidney disease.
Johansen KL, Cobitz AR, Singh AK, Macdougall IC, Lopes RD, Obrador GT, Kovesdy CP, Israni R, Jha V, Okoro T, Sprys M, Jolly S, Lindsay AC, Bhatt P, Camejo RR, Keeley T, Cizman B, Wheeler DC.
Johansen KL, et al. Among authors: camejo rr.
Kidney Int. 2023 Jun;103(6):1180-1192. doi: 10.1016/j.kint.2023.02.019. Epub 2023 Mar 2.
Kidney Int. 2023.
PMID: 36868377
Free article.
Clinical Trial.
Item in Clipboard
Clinical and Economic Outcomes of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Post-Bundling Era.
Cizman B, Smith HT, Camejo RR, Casillas L, Dhillon H, Mu F, Wu E, Xie J, Zuckerman P, Coyne D.
Cizman B, et al. Among authors: camejo rr.
Kidney Med. 2020 Aug 10;2(5):589-599.e1. doi: 10.1016/j.xkme.2020.06.008. eCollection 2020 Sep-Oct.
Kidney Med. 2020.
PMID: 33089137
Free PMC article.
Item in Clipboard
Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial.
Meininger V, Genge A, van den Berg LH, Robberecht W, Ludolph A, Chio A, Kim SH, Leigh PN, Kiernan MC, Shefner JM, Desnuelle C, Morrison KE, Petri S, Boswell D, Temple J, Mohindra R, Davies M, Bullman J, Rees P, Lavrov A; NOG112264 Study Group.
Meininger V, et al.
Lancet Neurol. 2017 Mar;16(3):208-216. doi: 10.1016/S1474-4422(16)30399-4. Epub 2017 Jan 28.
Lancet Neurol. 2017.
PMID: 28139349
Free article.
Clinical Trial.
Item in Clipboard
48-week efficacy and safety of dolutegravir relative to commonly used third agents in treatment-naive HIV-1-infected patients: a systematic review and network meta-analysis.
Patel DA, Snedecor SJ, Tang WY, Sudharshan L, Lim JW, Cuffe R, Pulgar S, Gilchrist KA, Camejo RR, Stephens J, Nichols G.
Patel DA, et al. Among authors: camejo rr.
PLoS One. 2014 Sep 4;9(9):e105653. doi: 10.1371/journal.pone.0105653. eCollection 2014.
PLoS One. 2014.
PMID: 25188312
Free PMC article.
Review.
Item in Clipboard
Assessing the determinants of the potential for cost-effectiveness over time: the empirical case of COPD.
Camejo RR, McGrath C, Herings R, Starkie H, Rutten F.
Camejo RR, et al.
Value Health. 2013 Mar-Apr;16(2):426-33. doi: 10.1016/j.jval.2012.11.006. Epub 2013 Jan 29.
Value Health. 2013.
PMID: 23538195
Free article.
Item in Clipboard
Cite
Cite